Molecular mechanisms of angiotensin II-induced vascular injury

被引:0
|
作者
Marta Ruiz-Ortega
Monica Ruperez
Vanesa Esteban
Jesús Egido
机构
[1] Fundación Jiménez Díaz,Vascular and Renal Research Laboratory
来源
关键词
Vascular Smooth Muscle Cell; Connective Tissue Growth Factor; Unilateral Ureteral Obstruction; Human Mesangial Cell; Glomerular Endothelial Cell;
D O I
暂无
中图分类号
学科分类号
摘要
Blockers of the renin-angiotensin system are used in the treatment of several cardiovascular and renal diseases, including hypertension, atherosclerosis, and cardiac failure. Angiotensin II plays an essential role in the pathogenesis of these diseases through the regulation of cell growth, inflammation, and fibrosis. There are two main angiotensin II receptors, AT1 and AT2. The AT1 receptor is responsible for most of the pathophysiologic actions of angiotensin II, including cell proliferation, production of growth factors and cytokines, and fibrosis. AT2 causes antiproliferation and counteracts the cell growth induced by AT1 activation. We review the mechanisms whereby AT1 and AT2 receptors elicit their respective actions. We discuss the current understanding of the signaling mechanisms involved in angiotensin II-induced vascular damage, describing the mediators (growth factors and cytokines) and intracellular signals (activation of protein kinases, transcription factors, and redox pathways) implicated in these processes, with special emphasis on novel information and open questions.
引用
收藏
页码:73 / 79
页数:6
相关论文
共 50 条
  • [21] Foxp3+T Regulatory Lymphocytes Counteract Angiotensin Ii-induced Vascular Injury
    Mian, Muhammad Oneeb Rehman
    Barhoumi, Tlili
    Briet, Marie
    Ene, Adriana Cristina
    Rehman, Asia
    Paradis, Pierre
    Schiffrin, Ernesto L.
    HYPERTENSION, 2014, 64
  • [22] Role of Vγ6+ γδ T Cells in Angiotensin II-Induced Hypertension and Vascular Injury
    Mahmoud, Ahmad
    Caillon, Antoine
    Paradis, Pierre
    Schiffrin, Ernesto L.
    HYPERTENSION, 2019, 74
  • [23] A molecular mechanism of angiotensin II-induced insulin resistance
    Taniyama, Y
    Shah, AD
    Alexander, RW
    Griendling, KK
    CIRCULATION, 2003, 108 (17) : 203 - 204
  • [24] Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations
    Tatchum-Talom, R
    Eyster, KM
    Martin, DS
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (05) : 413 - 422
  • [25] Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation
    da Cunha, V
    Tham, DM
    Martin-McNulty, B
    Deng, G
    Ho, JJ
    Wilson, DW
    Rutledge, JC
    Vergona, R
    Sullivan, ME
    Wang, YX
    ATHEROSCLEROSIS, 2005, 178 (01) : 9 - 17
  • [26] Angiotensin II-induced vascular response is enhanced by Extracellular Vesicles
    Wei, Jin
    Wu, Jing
    Musante, Luca
    Liu, Ruisheng
    Liu, Jing
    Greig, Morgan
    Harding, Michael
    Le, Thu
    Erdbruegger, Uta
    HYPERTENSION, 2024, 81
  • [27] Adiponectin ameliorates angiotensin II-induced vascular endothelial damage
    Zuo Zhi
    Zuo Pengfei
    Tian Xiaoyi
    Ma Genshan
    CELL STRESS & CHAPERONES, 2014, 19 (05): : 705 - 713
  • [28] Evidence for renal vascular remodeling in angiotensin II-induced hypertension
    Edgley, AJ
    Kett, MM
    Anderson, WP
    JOURNAL OF HYPERTENSION, 2003, 21 (07) : 1401 - 1406
  • [29] Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
    Zhang, Jingsi
    Hui, Yuanshu
    Liu, Fengyi
    Yang, Qian
    Lu, Yi
    Chang, Yeting
    Liu, Qinlong
    Ding, Yanchun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Impairment of vascular tetrahydrobiopterin metabolism in angiotensin II-induced hypertension
    d'Uscio, LV
    Pflueger, A
    Nath, KA
    Katusic, ZS
    HYPERTENSION, 2004, 44 (04) : 543 - 543